In this trial, ATH434 was compared to placebo in participants with early-stage MSA, including MSA-C. People with MSA-C are often misdiagnosed with cerebellar ataxia, because the symptoms can be similar in both conditions. This trial had sites in the UK.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type | 0 | 1746 | December 1, 2014 | |
| Maybe A Treatment Potential For Other Ataxias | 17 | 2203 | January 30, 2019 | |
| Hope for SCA | 4 | 763 | April 14, 2019 | |
| Troriluzole..optimism re SCA3 | 0 | 162 | May 24, 2022 | |
| I received that E-mail from NAF | 18 | 744 | December 18, 2019 |